{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:29:08Z","timestamp":1791163748049,"version":"4.1.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2011,5,13]],"date-time":"2011-05-13T00:00:00Z","timestamp":1305244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,5,13]],"date-time":"2011-05-13T00:00:00Z","timestamp":1305244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1038\/cdd.2011.53","type":"journal-article","created":{"date-parts":[[2011,5,13]],"date-time":"2011-05-13T09:00:47Z","timestamp":1305277247000},"page":"1425-1433","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":140,"title":["A deadly spread: cellular mechanisms of \u03b1-synuclein transfer"],"prefix":"10.1038","volume":"18","author":[{"given":"J A","family":"Steiner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Angot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Brundin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,13]]},"reference":[{"key":"BFcdd201153_CR1","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997; 276: 2045\u20132047.","journal-title":"Science"},{"key":"BFcdd201153_CR2","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ng0298-106","volume":"18","author":"R Kr\u00fcger","year":"1998","unstructured":"Kr\u00fcger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 1998; 18: 106\u2013108.","journal-title":"Nat Genet"},{"key":"BFcdd201153_CR3","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J et al. alpha-Synuclein locus triplication causes Parkinson's disease. Science 2003; 302: 841.","journal-title":"Science"},{"key":"BFcdd201153_CR4","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/ana.10795","volume":"55","author":"JJ Zarranz","year":"2004","unstructured":"Zarranz JJ, Alegre J, Gomez-Esteban JC, Lezcano E, Ros R, Ampuero I et al. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 2004; 55: 164\u2013173.","journal-title":"Ann Neurol"},{"key":"BFcdd201153_CR5","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","volume":"364","author":"MC Chartier-Harlin","year":"2004","unstructured":"Chartier-Harlin MC, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S et al. Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 2004; 364: 1167\u20131169.","journal-title":"Lancet"},{"key":"BFcdd201153_CR6","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/ng.485","volume":"41","author":"W Satake","year":"2009","unstructured":"Satake W, Nakabayashi Y, Mizuta I, Hirota Y, Ito C, Kubo M et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet 2009; 41: 1303\u20131307.","journal-title":"Nat Genet"},{"key":"BFcdd201153_CR7","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1038\/ng.487","volume":"41","author":"J Simon-Sanchez","year":"2009","unstructured":"Simon-Sanchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, Berg D et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet 2009; 41: 1308\u20131312.","journal-title":"Nat Genet"},{"key":"BFcdd201153_CR8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1469-1809.2009.00560.x","volume":"74","author":"TL Edwards","year":"2010","unstructured":"Edwards TL, Scott WK, Almonte C, Burt A, Powell EH, Beecham GW et al. Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann Hum Genet 2010; 74: 97\u2013109.","journal-title":"Ann Hum Genet"},{"key":"BFcdd201153_CR9","doi-asserted-by":"publisher","first-page":"27441","DOI":"10.1074\/jbc.M101318200","volume":"276","author":"JY Sung","year":"2001","unstructured":"Sung JY, Kim J, Paik SR, Park JH, Ahn YS, Chung KC . Induction of neuronal cell death by Rab5A-dependent endocytosis of alpha-synuclein. J Biol Chem 2001; 276: 27441\u201327448.","journal-title":"J Biol Chem"},{"key":"BFcdd201153_CR10","doi-asserted-by":"publisher","first-page":"6016","DOI":"10.1523\/JNEUROSCI.0692-05.2005","volume":"25","author":"HJ Lee","year":"2005","unstructured":"Lee HJ, Patel S, Lee SJ . Intravesicular localization and exocytosis of alpha-synuclein and its aggregates. J Neurosci 2005; 25: 6016\u20136024.","journal-title":"J Neurosci"},{"key":"BFcdd201153_CR11","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/j.biocel.2008.01.017","volume":"40","author":"HJ Lee","year":"2008","unstructured":"Lee HJ, Suk JE, Bae EJ, Lee JH, Paik SR, Lee SJ . Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein. Int J Biochem Cell Biol 2008; 40: 1835\u20131849.","journal-title":"Int J Biochem Cell Biol"},{"key":"BFcdd201153_CR12","doi-asserted-by":"publisher","first-page":"13010","DOI":"10.1073\/pnas.0903691106","volume":"106","author":"P Desplats","year":"2009","unstructured":"Desplats P, Lee HJ, Bae EJ, Patrick C, Rockenstein E, Crews L et al. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci USA 2009; 106: 13010\u201313015.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcdd201153_CR13","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1096\/fj.10-164624","volume":"25","author":"KM Danzer","year":"2010","unstructured":"Danzer KM, Ruf WP, Putcha P, Joyner D, Hashimoto T, Glabe C et al. Heat-shock protein 70 modulates toxic extracellular {alpha}-synuclein oligomers and rescues trans-synaptic toxicity. FASEB J 2010; 25: 326\u2013336.","journal-title":"FASEB J"},{"key":"BFcdd201153_CR14","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.1523\/JNEUROSCI.5699-09.2010","volume":"30","author":"E Emmanouilidou","year":"2010","unstructured":"Emmanouilidou E, Melachroinou K, Roumeliotis T, Garbis SD, Ntzouni M, Margaritis LH et al. Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J Neurosci 2010; 30: 6838\u20136851.","journal-title":"J Neurosci"},{"key":"BFcdd201153_CR15","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1471-4159.2010.06695.x","volume":"113","author":"A Jang","year":"2010","unstructured":"Jang A, Lee HJ, Suk JE, Jung JW, Kim KP, Lee SJ . Non-classical exocytosis of alpha-synuclein is sensitive to folding states and promoted under stress conditions. J Neurochem 2010; 113: 1263\u20131274.","journal-title":"J Neurochem"},{"key":"BFcdd201153_CR16","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1172\/JCI43366","volume":"121","author":"C Hansen","year":"2011","unstructured":"Hansen C, Angot E, Bergstr\u00f6m AL, Steiner JA, Pieri L, Paul G et al. Alpha-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells. J Clin Invest 2011; 121: 715\u2013725.","journal-title":"J Clin Invest"},{"key":"BFcdd201153_CR17","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1365-2990.2007.00874.x","volume":"33","author":"CH Hawkes","year":"2007","unstructured":"Hawkes CH, Del Tredici K, Braak H . Parkinson's disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol 2007; 33: 599\u2013614.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"BFcdd201153_CR18","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nm1747","volume":"14","author":"JH Kordower","year":"2008","unstructured":"Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW . Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat Med 2008; 14: 504\u2013506.","journal-title":"Nat Med"},{"key":"BFcdd201153_CR19","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1002\/mds.22369","volume":"23","author":"JH Kordower","year":"2008","unstructured":"Kordower JH, Chu Y, Hauser RA, Olanow CW, Freeman TB . Transplanted dopaminergic neurons develop PD pathologic changes: a second case report. Mov Disord 2008; 23: 2303\u20132306.","journal-title":"Mov Disord"},{"key":"BFcdd201153_CR20","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nm1746","volume":"14","author":"JY Li","year":"2008","unstructured":"Li JY, Englund E, Holton JL, Soulet D, Hagell P, Lees AJ et al. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat Med 2008; 14: 501\u2013503.","journal-title":"Nat Med"},{"key":"BFcdd201153_CR21","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1002\/mds.23012","volume":"25","author":"JY Li","year":"2010","unstructured":"Li JY, Englund E, Widner H, Rehncrona S, Bjorklund A, Lindvall O et al. Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease. Mov Disord 2010; 25: 1091\u20131096.","journal-title":"Mov Disord"},{"key":"BFcdd201153_CR22","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1001\/archneurol.2010.279","volume":"67","author":"IF Mata","year":"2010","unstructured":"Mata IF, Shi M, Agarwal P, Chung KA, Edwards KL, Factor SA et al. SNCA variant associated with Parkinson disease and plasma alpha-synuclein level. Arch Neurol 2010; 67: 1350\u20131356.","journal-title":"Arch Neurol"},{"key":"BFcdd201153_CR23","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M . Alpha-synuclein in Lewy bodies. Nature 1997; 388: 839\u2013840.","journal-title":"Nature"},{"key":"BFcdd201153_CR24","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb748","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS et al. alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 2002; 4: 160\u2013164.","journal-title":"Nat Cell Biol"},{"key":"BFcdd201153_CR25","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1172\/JCI200215777","volume":"110","author":"M Neumann","year":"2002","unstructured":"Neumann M, Kahle PJ, Giasson BI, Ozmen L, Borroni E, Spooren W et al. Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies. J Clin Invest 2002; 110: 1429\u20131439.","journal-title":"J Clin Invest"},{"key":"BFcdd201153_CR26","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/3311","volume":"4","author":"KA Conway","year":"1998","unstructured":"Conway KA, Harper JD, Lansbury PT . Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nat Med 1998; 4: 1318\u20131320.","journal-title":"Nat Med"},{"key":"BFcdd201153_CR27","doi-asserted-by":"publisher","first-page":"7619","DOI":"10.1074\/jbc.274.12.7619","volume":"274","author":"BI Giasson","year":"1999","unstructured":"Giasson BI, Uryu K, Trojanowski JQ, Lee VM . Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro. J Biol Chem 1999; 274: 7619\u20137622.","journal-title":"J Biol Chem"},{"key":"BFcdd201153_CR28","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0006-8993(98)00514-9","volume":"799","author":"M Hashimoto","year":"1998","unstructured":"Hashimoto M, Hsu LJ, Sisk A, Xia Y, Takeda A, Sundsmo M et al. Human recombinant NACP\/alpha-synuclein is aggregated and fibrillated in vitro: relevance for Lewy body disease. Brain Res 1998; 799: 301\u2013306.","journal-title":"Brain Res"},{"key":"BFcdd201153_CR29","doi-asserted-by":"publisher","first-page":"19509","DOI":"10.1074\/jbc.274.28.19509","volume":"274","author":"SJ Wood","year":"1999","unstructured":"Wood SJ, Wypych J, Steavenson S, Louis JC, Citron M, Biere AL . alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease. J Biol Chem 1999; 274: 19509\u201319512.","journal-title":"J Biol Chem"},{"key":"BFcdd201153_CR30","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1111\/j.1742-4658.2010.07721.x","volume":"277","author":"VN Uversky","year":"2010","unstructured":"Uversky VN . Mysterious oligomerization of the amyloidogenic proteins. FEBS J 2010; 277: 2940\u20132953.","journal-title":"FEBS J"},{"key":"BFcdd201153_CR31","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/S1474-4422(04)00827-0","volume":"3","author":"CW Olanow","year":"2004","unstructured":"Olanow CW, Perl DP, DeMartino GN, McNaught KS . Lewy-body formation is an aggresome-related process: a hypothesis. Lancet Neurol 2004; 3: 496\u2013503.","journal-title":"Lancet Neurol"},{"key":"BFcdd201153_CR32","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0079-6123(10)84014-2","volume":"184","author":"P Brundin","year":"2010","unstructured":"Brundin P, Barker RA, Parmar M . Neural grafting in Parkinson's disease: problems and possibilities. Prog Brain Res 2010; 184: 265\u2013294.","journal-title":"Prog Brain Res"},{"issue":"Suppl 3","key":"BFcdd201153_CR33","doi-asserted-by":"publisher","first-page":"III\/1","DOI":"10.1007\/s00415-002-1301-4","volume":"249","author":"H Braak","year":"2002","unstructured":"Braak H, Del Tredici K, Bratzke H, Hamm-Clement J, Sandmann-Keil D, R\u00fcb U . Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages). J Neurol 2002; 249 (Suppl 3): III\/1\u2013III\/5.","journal-title":"J Neurol"},{"key":"BFcdd201153_CR34","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nrn2477","volume":"9","author":"P Brundin","year":"2008","unstructured":"Brundin P, Li JY, Holton JL, Lindvall O, Revesz T . Research in motion: the enigma of Parkinson's disease pathology spread. Nat Rev Neurosci 2008; 9: 741\u2013745.","journal-title":"Nat Rev Neurosci"},{"key":"BFcdd201153_CR35","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/459924a","volume":"459","author":"A Aguzzi","year":"2009","unstructured":"Aguzzi A . Cell biology: beyond the prion principle. Nature 2009; 459: 924\u2013925.","journal-title":"Nature"},{"key":"BFcdd201153_CR36","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.neuron.2009.12.016","volume":"64","author":"A Aguzzi","year":"2009","unstructured":"Aguzzi A, Rajendran L . The transcellular spread of cytosolic amyloids, prions, and prionoids. Neuron 2009; 64: 783\u2013790.","journal-title":"Neuron"},{"issue":"Suppl 3","key":"BFcdd201153_CR37","doi-asserted-by":"publisher","first-page":"S143","DOI":"10.1016\/S1353-8020(09)70802-8","volume":"15","author":"E Angot","year":"2009","unstructured":"Angot E, Brundin P . Dissecting the potential molecular mechanisms underlying alpha-synuclein cell-to-cell transfer in Parkinson's disease. Parkinsonism Relat Disord 2009; 15 (Suppl 3): S143\u2013S147.","journal-title":"Parkinsonism Relat Disord"},{"key":"BFcdd201153_CR38","doi-asserted-by":"publisher","first-page":"206","DOI":"10.4161\/pri.3.4.10013","volume":"3","author":"C Krammer","year":"2009","unstructured":"Krammer C, Schatzl HM, Vorberg I . Prion-like propagation of cytosolic protein aggregates: insights from cell culture models. Prion 2009; 3: 206\u2013212.","journal-title":"Prion"},{"key":"BFcdd201153_CR39","doi-asserted-by":"publisher","first-page":"12571","DOI":"10.1073\/pnas.0906759106","volume":"106","author":"CW Olanow","year":"2009","unstructured":"Olanow CW, Prusiner SB . Is Parkinson's disease a prion disorder? Proc Natl Acad Sci USA 2009; 106: 12571\u201312572.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcdd201153_CR40","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/S1474-4422(10)70213-1","volume":"9","author":"E Angot","year":"2010","unstructured":"Angot E, Steiner JA, Hansen C, Li JY, Brundin P . Are synucleinopathies prion-like disorders? Lancet Neurol 2010; 9: 1128\u20131138.","journal-title":"Lancet Neurol"},{"key":"BFcdd201153_CR41","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrm2873","volume":"11","author":"P Brundin","year":"2010","unstructured":"Brundin P, Melki R, Kopito R . Prion-like transmission of protein aggregates in neurodegenerative diseases. Nat Rev Mol Cell Biol 2010; 11: 301\u2013307.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFcdd201153_CR42","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrn2786","volume":"11","author":"B Frost","year":"2010","unstructured":"Frost B, Diamond MI . Prion-like mechanisms in neurodegenerative diseases. Nat Rev Neurosci 2010; 11: 155\u2013159.","journal-title":"Nat Rev Neurosci"},{"key":"BFcdd201153_CR43","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/nrneurol.2010.145","volume":"6","author":"SJ Lee","year":"2010","unstructured":"Lee SJ, Desplats P, Sigurdson C, Tsigelny I, Masliah E . Cell-to-cell transmission of non-prion protein aggregates. Nat Rev Neurol 2010; 6: 702\u2013706.","journal-title":"Nat Rev Neurol"},{"key":"BFcdd201153_CR44","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1096\/fj.03-0098fje","volume":"17","author":"OM El-Agnaf","year":"2003","unstructured":"El-Agnaf OM, Salem SA, Paleologou KE, Cooper LJ, Fullwood NJ, Gibson MJ et al. Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma. FASEB J 2003; 17: 1945\u20131947.","journal-title":"FASEB J"},{"key":"BFcdd201153_CR45","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1096\/fj.03-1449com","volume":"20","author":"OM El-Agnaf","year":"2006","unstructured":"El-Agnaf OM, Salem SA, Paleologou KE, Curran MD, Gibson MJ, Court JA et al. Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease. FASEB J 2006; 20: 419\u2013425.","journal-title":"FASEB J"},{"key":"BFcdd201153_CR46","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.bbrc.2006.08.024","volume":"349","author":"T Tokuda","year":"2006","unstructured":"Tokuda T, Salem SA, Allsop D, Mizuno T, Nakagawa M, Qureshi MM et al. Decreased alpha-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease. Biochem Biophys Res Commun 2006; 349: 162\u2013166.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFcdd201153_CR47","doi-asserted-by":"crossref","unstructured":"Devic I, Hwang H, Edgar JS, Izutsu K, Presland R, Pan C et al. Salivary alpha-synuclein and DJ-1: potential biomarkers for Parkinson's disease. Brain 2011; e-pub ahead of print 24 February 2011.","DOI":"10.1093\/brain\/awr015"},{"key":"BFcdd201153_CR48","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1093\/brain\/awm318","volume":"131","author":"T Pan","year":"2008","unstructured":"Pan T, Kondo S, Le W, Jankovic J . The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease. Brain 2008; 131: 1969\u20131978.","journal-title":"Brain"},{"key":"BFcdd201153_CR49","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.nbd.2011.01.029","volume":"42","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti L, Seow Y, Schapira AH, Gardiner C, Sargent IL, Wood MJ et al. Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission. Neurobiol Dis 2011; 42: 360\u2013367.","journal-title":"Neurobiol Dis"},{"key":"BFcdd201153_CR50","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.1600-0854.2007.00677.x","volume":"9","author":"CM Fader","year":"2008","unstructured":"Fader CM, Sanchez D, Furlan M, Colombo MI . Induction of autophagy promotes fusion of multivesicular bodies with autophagic vacuoles in k562 cells. Traffic 2008; 9: 230\u2013250.","journal-title":"Traffic"},{"key":"BFcdd201153_CR51","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ceb.2009.03.007","volume":"21","author":"M Simons","year":"2009","unstructured":"Simons M, Raposo G . Exosomes--vesicular carriers for intercellular communication. Curr Opin Cell Biol 2009; 21: 575\u2013581.","journal-title":"Curr Opin Cell Biol"},{"key":"BFcdd201153_CR52","doi-asserted-by":"publisher","first-page":"9683","DOI":"10.1073\/pnas.0308413101","volume":"101","author":"B Fevrier","year":"2004","unstructured":"Fevrier B, Vilette D, Archer F, Loew D, Faigle W, Vidal M et al. Cells release prions in association with exosomes. Proc Natl Acad Sci USA 2004; 101: 9683\u20139688.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcdd201153_CR53","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1600-0854.2004.00247.x","volume":"6","author":"B Fevrier","year":"2005","unstructured":"Fevrier B, Vilette D, Laude H, Raposo G . Exosomes: a bubble ride for prions? Traffic 2005; 6: 10\u201317.","journal-title":"Traffic"},{"key":"BFcdd201153_CR54","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1002\/path.2145","volume":"211","author":"LJ Vella","year":"2007","unstructured":"Vella LJ, Sharples RA, Lawson VA, Masters CL, Cappai R, Hill AF . Packaging of prions into exosomes is associated with a novel pathway of PrP processing. J Pathol 2007; 211: 582\u2013590.","journal-title":"J Pathol"},{"key":"BFcdd201153_CR55","doi-asserted-by":"publisher","first-page":"11172","DOI":"10.1073\/pnas.0603838103","volume":"103","author":"L Rajendran","year":"2006","unstructured":"Rajendran L, Honsho M, Zahn TR, Keller P, Geiger KD, Verkade P et al. Alzheimer's disease beta-amyloid peptides are released in association with exosomes. Proc Natl Acad Sci USA 2006; 103: 11172\u201311177.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcdd201153_CR56","doi-asserted-by":"publisher","first-page":"25216","DOI":"10.1074\/jbc.M503341200","volume":"280","author":"JY Sung","year":"2005","unstructured":"Sung JY, Park SM, Lee CH, Um JW, Lee HJ, Kim J et al. Proteolytic cleavage of extracellular secreted {alpha}-synuclein via matrix metalloproteinases. J Biol Chem 2005; 280: 25216\u201325224.","journal-title":"J Biol Chem"},{"key":"BFcdd201153_CR57","doi-asserted-by":"publisher","first-page":"14168","DOI":"10.1074\/jbc.M111.222430","volume":"286","author":"DH Choi","year":"2011","unstructured":"Choi DH, Kim YJ, Kim YG, Joh TH, Beal MF, Kim YS . The role of matrix metalloproteinase 3-mediated alpha-synuclein cleavage in dopaminergic cell death. J Biol Chem 2011; 286: 14168\u201314177.","journal-title":"J Biol Chem"},{"key":"BFcdd201153_CR58","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/ncb1841","volume":"11","author":"K Gousset","year":"2009","unstructured":"Gousset K, Schiff E, Langevin C, Marijanovic Z, Caputo A, Browman DT et al. Prions hijack tunnelling nanotubes for intercellular spread. Nat Cell Biol 2009; 11: 328\u2013336.","journal-title":"Nat Cell Biol"},{"key":"BFcdd201153_CR59","doi-asserted-by":"publisher","first-page":"26292","DOI":"10.1074\/jbc.273.41.26292","volume":"273","author":"PH Jensen","year":"1998","unstructured":"Jensen PH, Nielsen MS, Jakes R, Dotti CG, Goedert M . Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation. J Biol Chem 1998; 273: 26292\u201326294.","journal-title":"J Biol Chem"},{"key":"BFcdd201153_CR60","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1046\/j.1460-9568.1999.00754.x","volume":"11","author":"PH Jensen","year":"1999","unstructured":"Jensen PH, Li JY, Dahlstrom A, Dotti CG . Axonal transport of synucleins is mediated by all rate components. Eur J Neurosci 1999; 11: 3369\u20133376.","journal-title":"Eur J Neurosci"},{"key":"BFcdd201153_CR61","doi-asserted-by":"publisher","first-page":"4645","DOI":"10.1242\/jcs.02558","volume":"118","author":"MA Utton","year":"2005","unstructured":"Utton MA, Noble WJ, Hill JE, Anderton BH, Hanger DP . Molecular motors implicated in the axonal transport of tau and alpha-synuclein. J Cell Sci 2005; 118: 4645\u20134654.","journal-title":"J Cell Sci"},{"key":"BFcdd201153_CR62","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1146\/annurev.cellbio.042308.113313","volume":"26","author":"PK Auluck","year":"2010","unstructured":"Auluck PK, Caraveo G, Lindquist S . alpha-Synuclein: membrane interactions and toxicity in Parkinson's disease. Annu Rev Cell Dev Biol 2010; 26: 211\u2013233.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"BFcdd201153_CR63","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1471-4159.2006.03731.x","volume":"97","author":"KJ Ahn","year":"2006","unstructured":"Ahn KJ, Paik SR, Chung KC, Kim J . Amino acid sequence motifs and mechanistic features of the membrane translocation of alpha-synuclein. J Neurochem 2006; 97: 265\u2013279.","journal-title":"J Neurochem"},{"key":"BFcdd201153_CR64","doi-asserted-by":"publisher","first-page":"6715","DOI":"10.1523\/JNEUROSCI.1594-04.2004","volume":"24","author":"DL Fortin","year":"2004","unstructured":"Fortin DL, Troyer MD, Nakamura K, Kubo S, Anthony MD, Edwards RH . Lipid rafts mediate the synaptic localization of alpha-synuclein. J Neurosci 2004; 24: 6715\u20136723.","journal-title":"J Neurosci"},{"key":"BFcdd201153_CR65","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/j.bbamcr.2008.06.010","volume":"1783","author":"P Zabrocki","year":"2008","unstructured":"Zabrocki P, Bastiaens I, Delay C, Bammens T, Ghillebert R, Pellens K et al. Phosphorylation, lipid raft interaction and traffic of alpha-synuclein in a yeast model for Parkinson. Biochim Biophys Acta 2008; 1783: 1767\u20131780.","journal-title":"Biochim Biophys Acta"},{"key":"BFcdd201153_CR66","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1021\/bi061749a","volume":"46","author":"Z Martinez","year":"2007","unstructured":"Martinez Z, Zhu M, Han S, Fink AL . GM1 specifically interacts with alpha-synuclein and inhibits fibrillation. Biochemistry (Mosc) 2007; 46: 1868\u20131877.","journal-title":"Biochemistry (Mosc)"},{"key":"BFcdd201153_CR67","doi-asserted-by":"publisher","first-page":"35722","DOI":"10.1074\/jbc.M701823200","volume":"282","author":"L Saavedra","year":"2007","unstructured":"Saavedra L, Mohamed A, Ma V, Kar S, de Chaves EP . Internalization of beta-amyloid peptide by primary neurons in the absence of apolipoprotein E. J Biol Chem 2007; 282: 35722\u201335732.","journal-title":"J Biol Chem"},{"key":"BFcdd201153_CR68","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/j.1471-4159.2009.06150.x","volume":"110","author":"JY Park","year":"2009","unstructured":"Park JY, Kim KS, Lee SB, Ryu JS, Chung KC, Choo YK et al. On the mechanism of internalization of alpha-synuclein into microglia: roles of ganglioside GM1 and lipid raft. J Neurochem 2009; 110: 400\u2013411.","journal-title":"J Neurochem"},{"key":"BFcdd201153_CR69","doi-asserted-by":"publisher","first-page":"9220","DOI":"10.1523\/JNEUROSCI.2617-07.2007","volume":"27","author":"KM Danzer","year":"2007","unstructured":"Danzer KM, Haasen D, Karow AR, Moussaud S, Habeck M, Giese A et al. Different species of alpha-synuclein oligomers induce calcium influx and seeding. J Neurosci 2007; 27: 9220\u20139232.","journal-title":"J Neurosci"},{"key":"BFcdd201153_CR70","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/j.1471-4159.2009.06324.x","volume":"111","author":"KM Danzer","year":"2009","unstructured":"Danzer KM, Krebs SK, Wolff M, Birk G, Hengerer B . Seeding induced by alpha-synuclein oligomers provides evidence for spreading of alpha-synuclein pathology. J Neurochem 2009; 111: 192\u2013203.","journal-title":"J Neurochem"},{"key":"BFcdd201153_CR71","doi-asserted-by":"publisher","first-page":"20051","DOI":"10.1073\/pnas.0908005106","volume":"106","author":"KC Luk","year":"2009","unstructured":"Luk KC, Song C, O\u2019Brien P, Stieber A, Branch JR, Brunden KR et al. Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc Natl Acad Sci USA 2009; 106: 20051\u201320056.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcdd201153_CR72","doi-asserted-by":"publisher","first-page":"34885","DOI":"10.1074\/jbc.M110.148460","volume":"285","author":"T Nonaka","year":"2010","unstructured":"Nonaka T, Watanabe ST, Iwatsubo T, Hasegawa M . Seeded aggregation and toxicity of {alpha}-synuclein and tau: cellular models of neurodegenerative diseases. J Biol Chem 2010; 285: 34885\u201334898.","journal-title":"J Biol Chem"},{"key":"BFcdd201153_CR73","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/j.1471-4159.2010.06592.x","volume":"113","author":"EA Waxman","year":"2010","unstructured":"Waxman EA, Giasson BI . A novel, high-efficiency cellular model of fibrillar alpha-synuclein inclusions and the examination of mutations that inhibit amyloid formation. J Neurochem 2010; 113: 374\u2013388.","journal-title":"J Neurochem"},{"key":"BFcdd201153_CR74","doi-asserted-by":"publisher","first-page":"9549","DOI":"10.1523\/JNEUROSCI.21-24-09549.2001","volume":"21","author":"L Stefanis","year":"2001","unstructured":"Stefanis L, Larsen KE, Rideout HJ, Sulzer D, Greene LA . Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death. J Neurosci 2001; 21: 9549\u20139560.","journal-title":"J Neurosci"},{"key":"BFcdd201153_CR75","doi-asserted-by":"publisher","first-page":"11753","DOI":"10.1074\/jbc.M208641200","volume":"278","author":"H Snyder","year":"2003","unstructured":"Snyder H, Mensah K, Theisler C, Lee J, Matouschek A, Wolozin B . Aggregated and monomeric alpha-synuclein bind to the S6\u2032 proteasomal protein and inhibit proteasomal function. J Biol Chem 2003; 278: 11753\u201311759.","journal-title":"J Biol Chem"},{"key":"BFcdd201153_CR76","doi-asserted-by":"publisher","first-page":"12924","DOI":"10.1074\/jbc.M306390200","volume":"279","author":"E Lindersson","year":"2004","unstructured":"Lindersson E, Beedholm R, Hojrup P, Moos T, Gai W, Hendil KB et al. Proteasomal inhibition by alpha-synuclein filaments and oligomers. J Biol Chem 2004; 279: 12924\u201312934.","journal-title":"J Biol Chem"},{"key":"BFcdd201153_CR77","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.neurobiolaging.2008.07.008","volume":"31","author":"E Emmanouilidou","year":"2010","unstructured":"Emmanouilidou E, Stefanis L, Vekrellis K . Cell-produced alpha-synuclein oligomers are targeted to, and impair, the 26S proteasome. Neurobiol Aging 2010; 31: 953\u2013968.","journal-title":"Neurobiol Aging"},{"key":"BFcdd201153_CR78","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/ncb1830","volume":"11","author":"PH Ren","year":"2009","unstructured":"Ren PH, Lauckner JE, Kachirskaia I, Heuser JE, Melki R, Kopito RR . Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates. Nat Cell Biol 2009; 11: 219\u2013225.","journal-title":"Nat Cell Biol"},{"key":"BFcdd201153_CR79","doi-asserted-by":"publisher","first-page":"RRN1210","DOI":"10.1371\/currents.RRN1210","volume":"3","author":"F Herrera","year":"2011","unstructured":"Herrera F, Tenreiro S, Miller-Fleming L, Outeiro TF . Visualization of cell-to-cell transmission of mutant huntingtin oligomers. PLoS Curr 2011; 3: RRN1210.","journal-title":"PLoS Curr"},{"key":"BFcdd201153_CR80","doi-asserted-by":"publisher","first-page":"e10627","DOI":"10.1371\/journal.pone.0010627","volume":"5","author":"R Chia","year":"2010","unstructured":"Chia R, Tattum MH, Jones S, Collinge J, Fisher EM, Jackson GS . Superoxide dismutase 1 and tgSOD1 mouse spinal cord seed fibrils, suggesting a propagative cell death mechanism in amyotrophic lateral sclerosis. PLoS One 2010; 5: e10627.","journal-title":"PLoS One"},{"key":"BFcdd201153_CR81","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.1073\/pnas.1017275108","volume":"108","author":"C M\u00fcnch","year":"2011","unstructured":"M\u00fcnch C, O\u2019Brien J, Bertolotti A . Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proc Natl Acad Sci USA 2011; 108: 3548\u20133553.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcdd201153_CR82","doi-asserted-by":"publisher","first-page":"12845","DOI":"10.1074\/jbc.M808759200","volume":"284","author":"B Frost","year":"2009","unstructured":"Frost B, Jacks RL, Diamond MI . Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem 2009; 284: 12845\u201312852.","journal-title":"J Biol Chem"},{"key":"BFcdd201153_CR83","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/ncb1901","volume":"11","author":"F Clavaguera","year":"2009","unstructured":"Clavaguera F, Bolmont T, Crowther RA, Abramowski D, Frank S, Probst A et al. Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 2009; 11: 909\u2013913.","journal-title":"Nat Cell Biol"},{"key":"BFcdd201153_CR84","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1126\/science.1082324","volume":"300","author":"BI Giasson","year":"2003","unstructured":"Giasson BI, Forman MS, Higuchi M, Golbe LI, Graves CL, Kotzbauer PT et al. Initiation and synergistic fibrillization of tau and alpha-synuclein. Science 2003; 300: 636\u2013640.","journal-title":"Science"},{"key":"BFcdd201153_CR85","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1126\/science.1131864","volume":"313","author":"M Meyer-Luehmann","year":"2006","unstructured":"Meyer-Luehmann M, Coomaraswamy J, Bolmont T, Kaeser S, Schaefer C, Kilger E et al. Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 2006; 313: 1781\u20131784.","journal-title":"Science"},{"key":"BFcdd201153_CR86","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.expneurol.2009.09.001","volume":"223","author":"RC Gaspar","year":"2010","unstructured":"Gaspar RC, Villarreal SA, Bowles N, Hepler RW, Joyce JG, Shughrue PJ . Oligomers of beta-amyloid are sequestered into and seed new plaques in the brains of an AD mouse model. Exp Neurol 2010; 223: 394\u2013400.","journal-title":"Exp Neurol"},{"key":"BFcdd201153_CR87","doi-asserted-by":"publisher","first-page":"12926","DOI":"10.1073\/pnas.0903200106","volume":"106","author":"YS Eisele","year":"2009","unstructured":"Eisele YS, Bolmont T, Heikenwalder M, Langer F, Jacobson LH, Yan ZX et al. Induction of cerebral beta-amyloidosis: intracerebral versus systemic Abeta inoculation. Proc Natl Acad Sci USA 2009; 106: 12926\u201312931.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcdd201153_CR88","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1126\/science.1194516","volume":"330","author":"YS Eisele","year":"2010","unstructured":"Eisele YS, Obermuller U, Heilbronner G, Baumann F, Kaeser SA, Wolburg H et al. Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis. Science 2010; 330: 980\u2013982.","journal-title":"Science"},{"key":"BFcdd201153_CR89","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.clim.2008.04.003","volume":"128","author":"P Villoslada","year":"2008","unstructured":"Villoslada P, Moreno B, Melero I, Pablos JL, Martino G, Uccelli A et al. Immunotherapy for neurological diseases. Clin Immunol 2008; 128: 294\u2013305.","journal-title":"Clin Immunol"},{"key":"BFcdd201153_CR90","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1096\/fj.03-1346fje","volume":"18","author":"OM El-Agnaf","year":"2004","unstructured":"El-Agnaf OM, Paleologou KE, Greer B, Abogrein AM, King JE, Salem SA et al. A strategy for designing inhibitors of alpha-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders. FASEB J 2004; 18: 1315\u20131317.","journal-title":"FASEB J"},{"key":"BFcdd201153_CR91","doi-asserted-by":"publisher","first-page":"7873","DOI":"10.1021\/ja075356q","volume":"130","author":"J Madine","year":"2008","unstructured":"Madine J, Doig AJ, Middleton DA . Design of an N-methylated peptide inhibitor of alpha-synuclein aggregation guided by solid-state NMR. J Am Chem Soc 2008; 130: 7873\u20137881.","journal-title":"J Am Chem Soc"}],"container-title":["Cell Death & Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cdd201153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cdd201153","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cdd201153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T18:18:48Z","timestamp":1712427528000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cdd201153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,13]]},"references-count":91,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["BFcdd201153"],"URL":"https:\/\/doi.org\/10.1038\/cdd.2011.53","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,13]]},"assertion":[{"value":"2 December 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}